1Department of Internal Medicine, University of Pisa, Italy.
This study investigated how red blood cells transfer electrons across their membranes in people with type 1 diabetes, focusing on those with and without kidney disease. Researchers found that people with diabetic nephropathy had higher electron transfer activity compared to those with retinopathy or no complications. This increase was linked to lower levels of glutathione (GSH) in red blood cells and correlated with kidney function markers like albumin excretion. The study also found that this change was not inherited, as siblings of diabetic patients had normal electron transfer. The findings suggest that electron transfer is a unique feature of diabetic nephropathy and may serve as a marker for kidney damage.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Prior research has shown that red blood cells (RBCs) can transfer reducing equivalents across membranes, involving ascorbate recycling. It was already known that glutathione (GSH) plays a central role in this process. However, the specific relationship between GSH depletion and transmembrane electron transfer in diabetes remains unclear. No prior work had resolved how this mechanism behaves in diabetic nephropathy versus other diabetic complications. This gap motivated the investigation of RBC GSH levels and electron transfer activity in patients with and without nephropathy. The study aimed to determine if electron transfer is uniquely affected in nephropathy. It was already known that diabetes can lead to oxidative stress and GSH depletion. However, the role of RBC electron transfer in diabetic nephropathy had not been fully explored.
Purpose Of The Study:
The researchers proposed to examine transmembrane electron transfer in type 1 diabetic patients with and without nephropathy. The specific problem is understanding how electron transfer is altered in diabetic nephropathy compared to other complications. This study aimed to measure RBC GSH levels and plasma sulfhydryl groups to assess oxidative stress. The motivation was to determine if electron transfer is uniquely increased in nephropathy. The researchers also sought to evaluate whether this change is hereditary or disease-specific. They hypothesized that electron transfer would correlate with renal function markers. The study focused on comparing patients with nephropathy to those with retinopathy and healthy controls. The goal was to identify if electron transfer is a specific indicator of nephropathy.
The study found that transmembrane electron transfer is selectively increased in diabetic nephropathy, with a strong correlation to renal function markers like urinary albumin excretion.
Electron transfer was measured by assessing ferrocyanide generation from ferricyanide reduction in red blood cells, using spectrophotometric methods.
RBC GSH is essential for ascorbate recycling, which supports transmembrane electron transfer. The study found lower GSH levels in diabetic nephropathy patients.
SH groups were measured to assess oxidative stress. They correlated with ferrocyanide generation in nephropathy but not in retinopathy patients.
Main Methods:
The study involved 30 type 1 diabetic patients divided into three groups: no complications, retinopathy, and nephropathy. Researchers measured RBC GSH, plasma sulfhydryl (SH) groups, and RBC-mediated ferricyanide reduction. They also included 36 siblings of diabetic patients and matched healthy volunteers for comparison. Blood samples were collected to assess fasting plasma glucose, HbA1c, and GSH levels. Plasma SH groups were quantified using spectrophotometric methods. Ferrocyanide generation was measured as an indicator of electron transfer activity. The researchers compared results between diabetic groups and control subjects. They analyzed correlations between electron transfer and renal function parameters. The study used statistical methods to evaluate differences between groups and associations between variables.
Main Results:
Diabetic patients had significantly lower RBC GSH levels and plasma SH groups compared to healthy controls. Patients with nephropathy showed higher ferrocyanide generation than those with retinopathy. RBC GSH was 0.73 mg/ml in the nephropathy group versus 0.85 mg/ml in the retinopathy group (P < 0.05). Ferrocyanide generation was 18 micromol/ml/h in nephropathy versus 14 in retinopathy (P < 0.05). Plasma SH groups were similar between the two diabetic groups but lower than in controls. Ferrocyanide generation correlated with urinary albumin excretion and plasma creatinine in the nephropathy group. In the uncomplicated group, electron transfer correlated with plasma lactate (r = 0.8, P = 0.01). No significant differences were found between siblings and healthy controls. The study showed that electron transfer is selectively increased in diabetic nephropathy.
Conclusions:
The authors propose that transmembrane electron transfer is selectively increased in diabetic nephropathy. This increase is associated with RBC GSH depletion and correlates with renal function markers. The abnormality is peculiar to the nephropathy group and not inherited, as siblings showed normal electron transfer. The relationship between cytosolic NADH and electron transfer observed in uncomplicated diabetes is lost in nephropathy. Patients with retinopathy alone still have normal RBC-reducing system activity. In nephropathy, increased electron transfer is unrelated to metabolic parameters like plasma lactate. The findings suggest that electron transfer is a specific indicator of nephropathy. The authors emphasize that this change is not due to familial or hereditary factors.
No, the study found normal electron transfer in siblings of diabetic patients, suggesting the change is specific to nephropathy and not hereditary.
The authors propose that increased electron transfer in nephropathy is linked to kidney dysfunction, as shown by correlations with urinary albumin and plasma creatinine.